HLA-A2.1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo

By Hwang Y.K.   Kim N.K.   Park J.M.   Lee K.-y.   Han W.-K.   Kim H.-I.   Cheong H.S.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3770-3777

Elsevier

Access to resources Recommend Favorite

Peptide vaccination using nonionic block copolymers induces protective anti-viral CTL responses

By Gibson Lanier J.   Newman M.J.   Lee E.M.   Sette A.   Ahmed R.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 549-557

Elsevier

Access to resources Recommend Favorite

Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity

By Kaufman H.L.   Flanagan K.   Lee C.S.D.   Perretta D.J.   Horig H.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1862-1869

Elsevier

Access to resources Recommend Favorite

Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses

By Oseroff C.   Sette A.   Wentworth P.   Celis E.   Maewal A.   Dahlberg C.   Fikes J.   Kubo R.T.   Chesnut R.W.   Grey H.M.   Alexander J.  

Vaccine, Vol. 16, Iss. 8, 1998-05 ,pp. : 823-833

Elsevier

Access to resources Recommend Favorite

Comparative efficiency of simple lipopeptide constructs for in vivo induction of virus-specific CTL

By Deprez B.   Sauzet J.-P.   Boutillon C.   Martinon F.   Tartar A.   Sergheraert C.   Guillet J.-G.   Gomard E.   Gras-Masse H.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 375-382

Elsevier

Access to resources Recommend Favorite